The trademark application FIDURSI was filed by AstraZeneca AB, a corporation established under the laws of the Kingdom of Sweden (the "Applicant"). The application was published for oppositions on January 17, 2016, and it was registered by office on April 25, 2016 without any oppositions.
The application was filed in English (German was selected as the second language).